Updated:
NYC Life Sciences Fund
Its offices in Princeton, Chicago, Shanghai, and Beijing imply a strategy that taps both the US East Coast and Chinese biotech ecosystems, though the fund's...
NYC Life Sciences Fund
Its offices in Princeton, Chicago, Shanghai, and Beijing imply a strategy that taps both the US East Coast and Chinese biotech ecosystems, though the fund's exact founding year and founding principals are not public. No named portfolio companies or co-investors have been publicly identified. The fund's stage coverage concentrates on seed and Series A rounds, typical of venture-style life sciences vehicles. Team size and total deployment are not disclosed. The fund maintains four offices, which is unusual for a single-region-focused vehicle and hints at a distributed operational model. No philanthropic arms or adjacent vehicles have been associated with the fund. As of 2025, no recent operational events have been reported. This gap between name and footprint may reflect regulatory or branding decisions rather than investment scope.
General information
Firm type
other
Location
Region
North America
Country
United States
City
Princeton
Corporate office
Princeton, NJ, United States
Additional offices
Chicago, IL, United States · Shanghai, China · Beijing, China
Sector focus
Frequently asked questions
Who runs investment decisions at NYC Life Sciences Fund?
The fund has not publicly named its managing partners or investment committee. No principals are listed on its website or in industry databases as of 2025. All investment decision-making structures remain undisclosed.
Does NYC Life Sciences Fund participate in fund commitments or only direct deals?
There is no public information about whether the fund allocates capital to other pooled vehicles or only invests directly in portfolio companies. Its investment vehicle usage — direct co-investments, SPVs, or fund-of-funds — is not disclosed.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: